] Filters: Author is Gasser, Thomas [Clear All Filters]
Carballo-Carbajal I, Weber-Endress S, Rovelli G, Chan D, Wolozin B, Klein CL, et al. Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cellular signalling. 2010.
0
Godau J, Herfurth M, Kattner B, Gasser T, Berg D. Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry. 2010.
Sharma M, Lichtner P, Kruger R, Berg D, Schulte C, Illig T, et al. Further delineation of the association signal on chromosome 5 from the first whole genome association study in Parkinson's disease. Neurobiol Aging. 2009;30(10):1706-9.
Klein CL, Rovelli G, Springer W, Schall C, Gasser T, Kahle PJ. Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. J Neurochem. 2009;111(3):703-15.
Maetzler W, Keller S, Michelis J, Koehler N, Stransky E, Becker C, et al. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases. Neurobiol Dis. 2009.
Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol. 2009;65(5):610-4.
Fuchs J, Mueller JC, Lichtner P, Schulte C, Munz M, Berg D, et al. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol Aging. 2009;30(5):731-8.
Koch A, Lehmann-Horn K, Dächsel JC, Gasser T, Kahle PJ, Lücking CB. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells. Parkinsonism Relat Disord. 2009;15(3):220-5.
Robottom BJ, Weiner WJ, Asmus F, Huber H, Gasser T, Schöls L. Kick and rush: paradoxical kinesia in Parkinson disease. Neurology. 2009;73(4):328; author reply 328-9.
Rothfuss O, Fischer H, Hasegawa T, Maisel M, Leitner P, Miesel F, et al. Parkin protects Mitochondrial Genome Integrity and supports Mitochondrial DNA Repair. Hum Mol Genet. 2009.
Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert reviews in molecular medicine. 2009;11:e22.
Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, Vieregge P, et al. Genes associated with Parkinson syndrome. J Neurol. 2008;255 Suppl 5:8-17.
Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer K, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet neurology. 2008;7(5):417-24.
Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA, et al. Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol. 2008;63(6):743-50.
Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet neurology. 2008;7(7):583-90.
Hoepken HH, Gispert S, Azizov M, Klinkenberg M, Ricciardi F, Kurz A, et al. Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp Neurol. 2008;212(2):307-13.
Exner N, Treske B, Paquet D, Holmström K, Schiesling C, Gispert S, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci. 2007;27(45):12413-8.
Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol. 2007;66(5):329-36.
Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol. 2007;66(4):251-7.
Taylor JP, Hulihan MM, Kachergus JM, Melrose HL, Lincoln SJ, Hinkle KM, et al. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics. 2007;8(2):95-102.
Klopstock T, Elstner M, Lücking CB, Müller-Myhsok B, Gasser T, Botz E, et al. Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease. Neurosci Lett. 2005;379(3):195-8.
Martinez M, Brice A, Vaughan JR, Zimprich A, Breteler MM, Meco G, et al. Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet. 2005;136B(1):72-4.
Buervenich S, Carmine A, Galter D, Shahabi HN, Johnels B, Holmberg B, et al. A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol. 2005;62(1):74-8.